Cipla Share: Pharma company announces purchase of 100% stake

Pharmaceutical company Cipla announced in an exchange filing after market hours that it will acquire 100% stake in Inzpera Healthsciences Limited. The deal will be completed for approximately ₹120 crore. Following the acquisition, Inzpera will become a wholly-owned subsidiary of Cipla. Inzpera Healthsciences was founded in 2016 and is engaged in the development, manufacturing, and marketing of pediatric medicines and wellness products in India.

Cipla states that this acquisition is a strategic move for the company, combining Inzpera’s extensive pediatric and wellness product portfolio with Cipla’s strong distribution network and operational capabilities. This will further accelerate the company’s growth and expansion potential. The acquisition is expected to be completed within one month from the date of signing of the transaction documents.